Effect of vitamin A in patients with COVID19

evaluation the effect of vitamin A on respiratory signs and hospitalization in patients with COVID-19

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170117032004N3

Enrollment

Registered

2020-03-29

Start date

2020-04-03

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1. Confirmed cases

Interventions

Intervention 1: Intervention group: 50000 Vitamin A daily for two weeks. Intervention 2: Control group: common treatment.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: confirmed diagnosis of COVID19 with RT-PCR hospitalized patients ventilator independent patients

Exclusion criteria

Exclusion criteria: being pregnant, lactating mothers, not consent to participate in the study using high-dose vitamin A in last month

Design outcomes

Primary

Measure	Time frame
Clinical response. Timepoint: until discharge from hospital. Method of measurement: Questionnaire.	—

Secondary

Measure	Time frame
Hospitalization period. Timepoint: at the end of study. Method of measurement: medical record review.;Mechanical ventilation need. Timepoint: During the study. Method of measurement: medical record review.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Nikniaz

Tabriz University of Medical Sciences

znikniaz@hotmail.com+98 41 3335 1688

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026